4,582
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models

, , , , , , , , , , , , , , , & show all
Pages 1108-1121 | Received 04 Apr 2019, Accepted 20 Jun 2019, Published online: 25 Jul 2019

References

  • Bodaghi S, Wood LV, Roby G, et al. Could human papillomaviruses be spread through blood? J Clin Microbiol. 2005;43:5428–5434. doi:10.1128/JCM.43.11.5428-5434.2005.
  • Taberna M, Mena M, Pavon MA, et al. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017;28:2386–2398. doi:10.1093/annonc/mdx304.
  • Agalliu I, Chen Z, Wang T, et al. Oral Alpha, Beta and Gamma HPV types and risk of incident esophageal cancer. Cancer Epidemiol Biomarkers Prev. 2018. doi:10.1158/1055-9965.EPI-18-0287.
  • Shikova E, Ivanova Z, Alexandrova D, et al. Human papillomavirus prevalence in lung carcinomas in Bulgaria. Microbiol Immunol. 2017;61:427–432. doi:10.1111/1348-0421.12535.
  • Bodaghi S, Yamanegi K, Xiao SY, et al. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res. 2005;11:2862–2867. doi:10.1158/1078-0432.CCR-04-1680.
  • Baandrup L, Thomsen LT, Olesen TB, et al. The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: a systematic review and meta-analysis. Eur J Cancer. 2014;50:1446–1461. doi:S0959-8049(14)00092-6 [pii];10.1016/j.ejca.2014.01.019 [doi] doi: 10.1016/j.ejca.2014.01.019
  • Tachezy R, Hrbacek J, Heracek J, et al. HPV persistence and its oncogenic role in prostate tumors. J Med Virol. 2012;84:1636–1645. doi:10.1002/jmv.23367.
  • Glenn WK, Ngan CC, Amos TG, et al. High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer. Infect Agent Cancer. 2017;12:46. doi:10.1186/s13027-017-0157-2.
  • Malhone C, Longatto-Filho A, Filassi JR. Is human papilloma virus associated with breast cancer? A review of the molecular evidence. Acta Cytol. 2018;62:166–177. doi:10.1159/000487700.
  • ElAmrani A, Gheit T, Benhessou M, et al. Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer. Papillomavirus Res. 2018;5:150–155. doi:10.1016/j.pvr.2018.04.003.
  • Mirzaei H, Goudarzi H, Eslami G, et al. Role of viruses in gastrointestinal cancer. J Cell Physiol. 2018;233:4000–4014. doi:10.1002/jcp.26194.
  • Zeng ZM, Luo FF, Zou LX, et al. Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases. Onco Targets Ther. 2016;9:7105–7114. doi:10.2147/OTT.S115053.
  • Martinez GG, Troconis JN. [Natural history of the infection for human papillomavirus: an actualization]. Invest Clin. 2014;55:82–91.
  • Doorbar J. Model systems of human papillomavirus-associated disease. J Pathol. 2016;238:166–179. doi:10.1002/path.4656.
  • Cladel NM, Peng X, Christensen N, et al. The rabbit papillomavirus model: a valuable tool to study viral-host interactions. Philos Trans R Soc Lond B Biol Sci. 2019;374:20180294. doi:10.1098/rstb.2018.0294.
  • Hu J, Cladel NM, Budgeon LR, et al. The mouse papillomavirus infection model. Viruses. 2017;9; doi:10.3390/v9090246.
  • Uberoi A, Lambert PF. Rodent papillomaviruses. Viruses. 2017;9; doi:10.3390/v9120362.
  • Brandsma JL. The cottontail rabbit papillomavirus model of high-risk HPV-induced disease. Methods Mol. Med. 2005;119:217–235.
  • Cladel NM, Budgeon LR, Balogh KK, et al. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer. Sci Rep. 2017;7:16932. doi:10.1038/s41598-017-17089-4.
  • Cladel NM, Budgeon LR, Cooper TK, et al. Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy. J Gen Virol. 2017. doi:10.1099/jgv.0.000926.
  • Cladel NM, Budgeon LR, Cooper TK, et al. Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus. J. Virol. 2013;87:9391–9395. doi:JVI.00777-13 [pii];10.1128/JVI.00777-13 [doi] doi: 10.1128/JVI.00777-13
  • Hu J, Budgeon LR, Cladel NM, et al. Detection of L1, infectious virions and anti-L1 antibody in domestic rabbits infected with cottontail rabbit papillomavirus. J. Gen. Virol. 2007;88:3286–3293. doi: 10.1099/vir.0.82879-0
  • Cladel NM, Budgeon LR, Balogh KK, et al. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue. Virology. 2016;488:73–80. doi:10.1016/j.virol.2015.10.030.
  • Hu J, Budgeon LR, Cladel NM, et al. Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model. J Gen Virol. 2015;96:3554–3565. doi:10.1099/jgv.0.000295.
  • Cladel NM, Hu J, Balogh K, et al. Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection. J Virol Methods. 2008;148:34–39. doi: 10.1016/j.jviromet.2007.10.005
  • Kreider JW, Cladel NM, Patrick SD, et al. High efficiency induction of papillomas in vivo using recombinant cottontail rabbit papillomavirus DNA. J Virol Methods. 1995;55:233–244. doi: 10.1016/0166-0934(95)00062-Y
  • Xiao W, Brandsma JL. High efficiency, long-term clinical expression of cottontail rabbit papillomavirus (CRPV) DNA in rabbit skin following particle-mediated DNA transfer. Nucleic Acids Res. 1996;24:2620–2622. doi: 10.1093/nar/24.13.2620
  • Cladel NM, Hu J, Balogh KK, et al. Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model. J Virol Methods. 2010;165:36–41. doi: 10.1016/j.jviromet.2009.12.014
  • Hu J, Budgeon LR, Balogh KK, et al. Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits. Trials Vaccinol. 2014;3:134–142. doi:10.1016/j.trivac.2014.06.002.
  • Xue XY, Majerciak V, Uberoi A, et al. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. PLoS Pathog. 2017;13:e1006715. doi:10.1371/journal.ppat.1006715.
  • Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120. doi:10.1093/bioinformatics/btu170.
  • Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi:10.1093/bioinformatics/bts635.
  • Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi:10.1186/1471-2105-12-323.
  • Phipson B, Lee S, Majewski IJ, et al. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. 2016;10:946–963. doi:10.1214/16-AOAS920.
  • Metsalu T, Vilo J. Clustvis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43:W566–W570. doi:10.1093/nar/gkv468.
  • Hu J, Cladel N, Balogh K, et al. Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits. Vaccine. 2010;28:3706–3713. doi:10.1016/j.vaccine.2010.03.015.
  • Cladel NM, Budgeon LR, Balogh KK, et al. A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. PLoS One. 2015;10:e0120128. doi:10.1371/journal.pone.0120128.
  • Cocuzza CE, Martinelli M, Sina F, et al. Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia. PLoS One. 2017;12:e0188592. doi:10.1371/journal.pone.0188592.
  • Jeannot E, Becette V, Campitelli M, et al. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma. J Pathol Clin Res. 2016;2:201–209. doi:10.1002/cjp2.47.
  • Chen AC, Keleher A, Kedda MA, et al. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol. 2009;81:1792–1796. doi:10.1002/jmv.21592.
  • Hu J, Cladel NM, Pickel MD, et al. Amino Acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus e6 influence spontaneous regression of cutaneous papillomas. J. Virol. 2002;76:11801–11808. doi: 10.1128/JVI.76.23.11801-11808.2002
  • Laffort C, Le Deist F, Favre M, et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet. 2004;363:2051–2054. doi: 10.1016/S0140-6736(04)16457-X
  • Shanis D, Anandi P, Grant C, et al. Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study. Bone Marrow Transplant. 2018;53:78–83. doi:10.1038/bmt.2017.210.
  • Stramer SL. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser. 2014;9:30–36. doi:10.1111/voxs.12070.
  • Russo GI, Calogero AE, Condorelli RA, et al. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis. Aging Male. 2018: 1–7. doi:10.1080/13685538.2018.1455178.
  • Akhtar N, Bansal JG. Risk factors of lung cancer in nonsmoker. Curr Probl Cancer. 2017;41:328–339. doi:10.1016/j.currproblcancer.2017.07.002.
  • Salyakina D, Tsinoremas NF. Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data. Hum Genomics. 2013;7:23. doi:10.1186/1479-7364-7-23.
  • Damin DC, Caetano MB, Rosito MA, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol. 2007;33:569–574. doi:10.1016/j.ejso.2007.01.014.
  • Shigehara K, Sasagawa T, Namiki M. Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review. J Infect Chemother. 2014;20:741–747. doi:10.1016/j.jiac.2014.08.033.
  • Campo MS. Animal models of papillomavirus pathogenesis. Virus Res. 2002;89:249–261. doi: 10.1016/S0168-1702(02)00193-4
  • Zha H, Li X, Sun H, et al. S100a9 promotes the proliferation and migration of cervical cancer cells by inducing epithelialmesenchymal transition and activating the Wnt/betacatenin pathway. Int J Oncol. 2019;55:35–44. doi:10.3892/ijo.2019.4793.
  • Tang S, Gao L, Bi Q, et al. SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma. PLoS One. 2013;8:e52184. doi:10.1371/journal.pone.0052184.
  • Zhussupbekova S, Sinha R, Kuo P, et al. A mouse model of hyperproliferative human epithelium validated by keratin profiling shows an aberrant cytoskeletal response to injury. EBioMedicine. 2016;9:314–323. doi:10.1016/j.ebiom.2016.06.011.
  • Liu MY, Zhang H, Hu YJ, et al. Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray. Oncol Lett. 2016;12:473–478. doi:10.3892/ol.2016.4658.
  • Xu Y, Li F, Lv L, et al. Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase. Cancer Res. 2014;74:3630–3642. doi:10.1158/0008-5472.CAN-13-3615.
  • Vartanian JP, Guetard D, Henry M, et al. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science. 2008;320:230–233. doi:10.1126/science.1153201.
  • Bierkens M, Krijgsman O, Wilting SM, et al. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer. 2013;52:56–68. doi:10.1002/gcc.22006.
  • Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017;9; doi:10.3390/v9100267.
  • Shew ML, Ermel AC, Tong Y, et al. Episodic detection of human papillomavirus within a longitudinal cohort of young women. J Med Virol. 2015;87:2122–2129. doi:10.1002/jmv.24284.
  • Moustafa A, Xie C, Kirkness E, et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017;13:e1006292), doi:10.1371/journal.ppat.1006292.